You cant out-exercise a poor diet, Dr
While our analysis identified significant pharmacovigilance signals, we emphasize these findings represent associations rather than established causation
Louisiana Medicaid might add coverage for popular obesity treatment drugs Louisianas Medicaid program could expand access to popular weight-loss medications such as Wegovy and Zepbound for obesity treatment starting in January
No serious dose-limiting toxicities or unexpected safety signals were identified in Phase 1 trials, supporting progression to Phase 2 development
Prioritize sleep: Talk to your healthcare provider if you experience side effects that impact your sleep, such as nighttime urination, reflux and snoring/suspected sleep apnea
There are FDA-approved alternatives to compounded tirzepatide for type 2 diabetes, weight loss, or weight management, including: Keep in mind that these drugs may be FDA-approved for specific uses